Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia worldwide. It leads to gradual cognitive decline, memory loss, and impaired daily functioning. However, there is still a lot that scientists don’t know yet about the disease.

To address these gaps, researchers rely on Alzheimer’s Disease Serum Samples and plasma specimens. These samples help them study disease mechanisms, identify biomarkers, and advance Alzheimer’s disease treatment strategies.

At Bay Biosciences, we understand this need and provide high-quality, well-characterized serum and plasma biospecimens to support translational and clinical research in neurodegenerative diseases.

Alzheimer’s Disease Samples for Clinical Research

Understanding Alzheimer’s Disease Pathology

Alzheimer’s disease results from complex pathological processes in the brain, primarily involving the accumulation of amyloid-beta plaques and tau protein tangles.

  • Plaques (beta-amyloid): Beta-amyloid forms when protein fragments stick together. These clumps block communication between brain cells and form larger deposits called plaques.
  • Tangles (tau protein): Neurofibrillary (tau) tangles form when tau protein accumulates and twists into abnormal fibers. These tangles disrupt the cell’s internal transport system, blocking the movement of nutrients and other essential substances.

These abnormalities lead to:

  • Neuronal damage and synaptic dysfunction
  • Neuroinflammation
  • Progressive brain atrophy

Researchers analyze Alzheimer’s Disease Serum Samples and plasma specimens to measure biomarkers such as NfL/ Aβ1–42, which help in the study of neurodegeneration associated with Alzheimer’s disease.

This blood-based research is valuable because it offers a less invasive alternative to cerebrospinal fluid (CSF) sampling and supports large-scale screening and longitudinal studies.

Risk Factors of Alzheimer’s Disease

Scientists do not fully understand the exact cause of Alzheimer’s disease.

However, it is widely understood that a combination of genetic, lifestyle, and environmental factors leads to Alzheimer’s over time.

Some common factors  that increase the risk of developing Alzheimer’s disease include:

1. Older Age

Age is the strongest risk factor. Alzheimer’s is not a normal part of aging, but risk increases significantly as people grow older.

2. Family History and Genetics

People with a parent or sibling who has Alzheimer’s face a higher risk. Genes influence this risk in complex ways. A specific gene, APOE e4, increases the likelihood of developing the disease. However, not everyone with this gene develops Alzheimer’s.

3. Air Pollution

Exposure to polluted air can damage the nervous system and increase dementia risk.

4. Heavy Alcohol Use

Excessive alcohol consumption causes brain damage and increases the risk of early-onset dementia.

5. Lifestyle and Heart Health

Factors such as obesity, smoking, high blood pressure, and cholesterol levels also increase Alzheimer’s risk.

6. Hearing & Vision Loss

Hearing loss can increase dementia risk when hearing aids aren’t used. Similarly, uncorrected vision problems can also increase the risk of cognitive decline.

7. Diabetes

Type 2 diabetes increases the risk of developing dementia.

8. Depression

Depression is linked to a higher risk of dementia. It can appear early, even before clear dementia symptoms develop. Depression and dementia may influence each other, and both can occur together.

Stages of Alzheimer’s Disease

Understanding the stages of Alzheimer’s disease helps researchers and clinicians track disease progression and tailor interventions.

Preclinical Stage

In this early stage, pathological changes begin in the brain years before symptoms appear. Biomarkers detected in serum and plasma may reveal early disease activity.

Mild Dementia Due to Alzheimer’s Disease

This stage involves significant cognitive decline, memory loss, and functional impairment. Biomarker levels often correlate with disease severity.

Moderate Dementia Due to Alzheimer’s Disease

In moderate dementia, confusion and memory loss worsen. People need more help with daily tasks and self-care. They forget personal details, lose track of time, and may confuse family members or strangers. Behavior changes such as suspicion, agitation, restlessness, and occasional aggression can appear.

Severe Dementia Due to Alzheimer’s Disease

In severe dementia, mental and physical abilities decline further, and full-time care is required. Patients can no longer converse meaningfully and may speak only occasionally.
Complete assistance is needed for eating, dressing, toileting, and personal care. Moreover, physical decline is pronounced: muscles may stiffen, reflexes weaken, swallowing becomes difficult, and bladder and bowel control are lost.

Frontal Lobe Alzheimer’s and Regional Brain Impact

While Alzheimer’s disease typically affects memory-related regions such as the hippocampus, some variants involve other brain areas, including the frontal lobe.

Frontal lobe Alzheimer’s may present with:

  • Changes in behavior and personality
  • Impaired decision-making
  • Reduced executive function

Alzheimer’s and Weight Loss

Weight loss is a common feature of Alzheimer’s disease, particularly as the condition progresses.

It can occur due to multiple factors, including reduced appetite, impaired sense of smell and taste, difficulty recognizing food, and challenges with chewing or swallowing.

In later stages, metabolic changes and increased energy expenditure may further contribute to unintentional weight loss.

Best Way to Prevent Alzheimer’s

The best way to prevent Alzheimer’s focuses on modifiable lifestyle and health factors, including:

  • Maintaining cardiovascular health
  • Regular physical activity
  • Cognitive stimulation and mental engagement
  • Balanced nutrition
  • Managing chronic conditions such as diabetes and hypertension

Researchers also explore preventive biomarkers using Alzheimer’s Disease Serum Samples, aiming to identify individuals at risk before symptoms develop.

Treatment of Alzheimer's Disorder

Alzheimer’s treatment focuses on slowing down the decline and effectively managing symptoms.

Prominent treatment options include the use of two types of drugs:

  1. Symptom-relief drugs that help stabilize symptoms related to memory, thinking, and behavior for a limited time.
  2. Disease-modifying drugs such as Donanemab and Lecanemab that slow down cognitive decline and overall progression of the disease.

Importance of Serum and Plasma in Alzheimer’s Research

Serum and plasma play a critical role in Alzheimer’s research by allowing scientists to study systemic changes linked to disease progression.

Serum forms after blood clots and contains proteins, peptides, antibodies, hormones, and metabolic biomarkers. Researchers use Alzheimer’s Disease Serum Samples to analyze disease-specific protein patterns and immune responses.

Plasma, in contrast, is collected using anticoagulants and retains clotting factors. It contains fibrinogen, coagulation proteins, circulating RNA and DNA, and extracellular vesicles. These components support deeper molecular analysis. Plasma biomarkers are valuable for early-stage identification of Alzheimer’s disease.

Together, serum and plasma provide complementary insights that help researchers better understand Alzheimer’s disease mechanisms and improve diagnostic and therapeutic strategies.

Supporting Your Research With Bay Biosciences

Advancing Alzheimer’s disease treatment requires a deeper understanding of disease mechanisms, which is possible through serum and plasma samples.

However, the accuracy of research findings depends heavily on the quality of biospecimens.

At Bay Biosciences, we maintain high standards at every stage of handling by ensuring rapid sample collection and processing to preserve sample integrity.

We also store all specimens under strictly controlled conditions to prevent degradation.

Our team adheres to standardized protocols to ensure consistency across studies.

We also prioritize ethical sourcing and full regulatory compliance to support reliable and responsible research outcomes.

Our wide range of samples that support Alzheimer’s research includes:

Samples from normal healthy donors, volunteers, for controls, and clinical research are also

available.

If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us!